⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

PT-141

Published Research

PubMed-indexed studies for PT-141

Research

PT-141 Palatin.

Current opinion in investigational drugs (London, England : 2000) 2004
View on PubMed →
Research

An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.

The journal of sexual medicine 2006
View on PubMed →
Research

Targeting the central melanocortin system for the treatment of metabolic disorders.

Nature reviews. Endocrinology 2023
View on PubMed →
Research

Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.

The Annals of pharmacotherapy 2020
View on PubMed →

Research-Grade PT-141

YPB.274
PT-141 (10mg)
$50.00
⚠️ For laboratory research only. Not for human use.